Wegovy has been widely known as a once-weekly injection for chronic weight management. That changed on December 22, 2025, when the US Food and Drug Administration approved Wegovy tablets.
This made Wegovy pills the first GLP-1 receptor agonist pill approved specifically for long-term weight reduction in adults with obesity or overweight with weight-related medical problems, and also for cardiovascular risk reduction in certain adults with established cardiovascular disease.
If you have been curious about this new diet pill approved by the FDA, this guide walks through what the Wegovy pill is, what the evidence shows, who it is for, how to take it correctly, what it costs, and how to buy it safely from reputable sources.
What is the Wegovy pill?
The Wegovy pill is the first GLP-1 weight-loss medication in pill form approved in the United States.
It is taken by mouth once a day and is meant to be used alongside a lower-calorie diet and regular physical activity. It is approved for adults with obesity, as well as adults who are overweight and have weight-related health conditions.
In addition to helping with weight loss, the Wegovy pill is also approved to help lower the risk of serious heart problems. This includes heart attack, stroke, or death from cardiovascular disease in adults who are overweight or obese and already have heart disease.
How much weight can you lose with the Wegovy pill?
Its FDA approval was based on results from a large clinical study called the OASIS 4 trial. This 64-week study included 307 adults with obesity or overweight who had at least one weight-related medical condition but did not have diabetes.
Everyone was instructed to follow a reduced-calorie diet and increase their physical activity.
Participants who took the Wegovy pill once daily lost an average of about 14% of their body weight. That equals roughly 33 lbs, based on an average starting weight of 235 lbs. In comparison, people taking a placebo lost about 2% of their body weight.
Among participants who stayed on the medication for the full study, average weight loss reached nearly 17% with the Wegovy pill, compared with less than 3% for placebo.
The results also showed that many people achieved meaningful weight loss:
-
- 76% of adults taking Wegovy lost 5% or more of their body weight, compared with 31% taking a placebo
- 60% lost 10% or more, compared with 14% on placebo
- 47% lost 15% or more, compared with 6% on placebo
Some participants lost even more weight. About 1 in 4 adults (28%) taking Wegovy lost 20% or more of their body weight, which equals roughly 47 lbs from a starting weight of 235 lbs. Only 3% of adults taking placebo reached this level of weight loss.
What are the side effects of the pill?
The side effects reported with the Wegovy tablet were similar to those already known for other Wegovy treatments. These include:
-
- nausea
- diarrhea
- vomiting
- constipation
- abdominal pain
- headache
- fatigue
- indigestion
During the study, a small number of people stopped taking the medication because of side effects. About 7% of people taking the Wegovy tablet stopped treatment for this reason, compared with about 6% of people taking a placebo.
The most common reason for stopping was digestive side effects, such as nausea or stomach discomfort.
Wegovy also has warnings and precautions that you should review with a clinician, including:
-
- Risk of thyroid C-cell tumors
- Acute pancreatitis
- Acute gallbladder disease, including cholelithiasis and cholecystitis
- Acute kidney injury, often related to dehydration from gastrointestinal side effects
- Severe gastrointestinal adverse reactions
- Hypoglycemia risk
- Suicidal behavior and ideation warning
- Pulmonary aspiration in patients undergoing anesthesia or deep sedation
Wegovy pill dose titration schedule
Wegovy tablets come in four strengths:
-
- 1.5 mg
- 4 mg
- 9 mg
- 25 mg
Its dosing starts low and increases gradually to help your body adjust and reduce side effects.
Your healthcare provider will begin treatment with 1.5 mg once daily. The dose is then increased every 30 days until you reach the target dose of 25 mg once daily, which is the highest approved dose.
| Treatment Phase | Time Period | Tablet (Once Daily) |
| Starting phase | Weeks 1-4 / Days 1-30 | 1.5 mg |
| Dose increase 1 | Weeks 5-8 / Days 31-60 | 4 mg |
| Dose increase 2 | Weeks 9-12 / Days 61-90 | 9 mg |
| Ongoing dose | Weeks 13-16 / Day 91 onward | 25 mg |
Not everyone moves up at the same pace, and your provider may adjust the schedule based on how well you tolerate the medication.
If you forget to take a dose, skip it and take your next dose the following day at your usual time. Do not take two pills to make up for a missed dose.
How to take the Wegovy pill?
The Wegovy pill is designed to be taken once a day and can easily fit into a morning routine.
When you wake up, take one Wegovy pill with a small amount of plain water, no more than 4 ounces. Your stomach should be empty when you take it.
After taking the pill, wait at least 30 minutes before eating, drinking anything else, or taking other oral medications. This waiting period helps your body absorb the medication properly.
For best results, take Wegovy the same way every day. Swallow the pill whole. Do not crush, chew, split, or dissolve it. Use only water, not coffee, juice, or other drinks. Keep the pills stored in the original bottle until you are ready to take one, and never take more than one pill in a single day.
Switching between Wegovy injections and Wegovy tablets
It’s possible to switch between the injectable form of Wegovy and the tablet form. This can be done safely when timed correctly.
-
- Switching from Wegovy injection to Wegovy tablet – If you are currently using the Wegovy 2.4 mg weekly injection for weight loss or heart risk reduction, you may switch to the tablet version. To do this, stop the injection first. One week after your last injection, you can begin taking Wegovy 25 mg tablets once daily by mouth.
-
- Switching from Wegovy tablet to Wegovy injection – If you are taking Wegovy 25 mg tablets once daily, you may switch to the injectable form. After stopping the tablets, you can start Wegovy 2.4 mg injections the very next day, given once weekly. If you had trouble tolerating the 25 mg tablet dose, your healthcare provider may start you on a lower injection dose of 1.7 mg once weekly instead.
For people with type 2 diabetes who need additional weight loss, switching from the 25 mg tablet to the 1.7 mg injection may also be considered. The injection dose can then be increased gradually following the standard injection dosing schedule.
Taking Wegovy tablets with other oral medications
Wegovy slows how quickly food moves through the stomach. This can change how some oral medications are absorbed into the body.
In studies using injectable semaglutide, the most common oral medications were not affected. However, when semaglutide was taken as a tablet, one medication stood out.
People who took levothyroxine (a thyroid medication) together with the Wegovy tablet had about 33% higher thyroid hormone levels in their blood, even though the peak level did not change. Because of this, people taking levothyroxine may need closer monitoring or dose adjustments.
For other commonly used medications, including blood pressure drugs, blood thinners, diabetes medicines, acid-reducing drugs, cholesterol medications, and birth control pills, no meaningful changes were seen when they were taken with semaglutide.
Specifically, oral semaglutide did not significantly affect drug levels when taken with:
-
- Omeprazole
- Lisinopril
- Warfarin (both S-warfarin and R-warfarin)
- Metformin
- Digoxin
- Ethinyl estradiol and levonorgestrel (components of oral birth control)
- Furosemide
- Rosuvastatin
Laboratory studies also showed that oral semaglutide has a very low likelihood of affecting liver enzymes (CYP enzymes) or drug transport systems that are responsible for how many medications are processed in the body. This further reduces the chance of drug-to-drug interactions.
Using Wegovy with insulin or diabetes medications
Wegovy can lower blood sugar. Because of this, taking it together with insulin or certain diabetes pills that increase insulin release, such as sulfonylureas, can raise the risk of low blood sugar.
Wegovy has not been fully studied in people who use insulin. If you take insulin or insulin-boosting medications, your healthcare provider may lower those doses when Wegovy is started to reduce the chance of hypoglycemia. Blood sugar levels may need closer monitoring during this time.
Who can use Wegovy tablets for weight loss?
Wegovy tablets are indicated for two major purposes in adults:
-
- Weight reduction and long-term weight maintenance in adults with obesity, or adults with overweight and at least one weight-related comorbid condition, used with a reduced-calorie diet and increased physical activity.
-
- Reduction of risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.
You may be eligible if:
-
- Your BMI is 30 or higher, which falls in the obesity range, or
-
- Your BMI is 27 or higher, and you also have at least one weight-related health condition, such as high blood pressure, high cholesterol, or heart disease.
Who should not use Wegovy tablets?
Wegovy has a boxed warning related to thyroid C-cell tumors, and it is contraindicated in people with:
-
- A personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2
It is also contraindicated in people with a known serious hypersensitivity reaction to semaglutide or the excipients in Wegovy tablets.
How much do Wegovy pills cost?
According to Novo Nordisk’s official pricing information, the list price for Wegovy tablets is $1,349.02 for a 30-tablet bottle, across all tablet strengths, including 1.5 mg, 4 mg, 9 mg, and 25 mg.
Novo Nordisk also promotes a self-pay option for people paying out of pocket. Under this program, monthly pricing starts at $149 for the 1.5 mg tablet and increases to $299 per month for the 9 mg and 25 mg doses. The 4 mg tablet is offered at $149 per month for new patients through April 15, 2026, after which the price increases to $199 per month. But you can only access these self-pay prices through select channels, including NovoCare Pharmacy and Amazon Pharmacy.
Outside of these programs, you will likely pay the full list price. Your real out-of-pocket cost depends mainly on:
-
- Whether your plan covers anti obesity medications
- Whether you meet your plan criteria, such as BMI thresholds and prior attempts at lifestyle changes
- Whether prior authorization is required
- Whether you have a copay card or a savings program
- Whether you are paying cash
Where to buy Wegovy pill and how to buy it safely?
The Wegovy pill is now widely accessible across the United States. Prescriptions can be filled at more than 70,000 retail pharmacies nationwide, including large chains such as CVS and Costco.
It is also offered through several online prescription services and telehealth platforms, including Ro, LifeMD, and Weight Watchers, as well as through NovoCare Pharmacy, GoodRx, and other prescription partners.
Be careful with online sellers and social media ads. High-demand weight loss drugs attract counterfeit and unapproved versions. The FDA has issued warnings about counterfeit semaglutide products in legitimate supply chains and encourages buying only from authorized sources.
If a website offers Wegovy tablets without a prescription, or ships from unknown sources, treat that as a major red flag.
Summary
The Wegovy pill offers an effective oral option for weight loss and heart risk reduction in eligible adults. Clinical trials show meaningful, sustained weight loss for many people when it is combined with diet and physical activity.
Proper dose titration, correct daily use, and awareness of side effects and drug interactions are important for safe treatment. Costs vary by coverage, and it should only be purchased from authorized pharmacies.
For those who qualify and prefer a pill over injections, Wegovy tablets provide a well-studied and convenient alternative under medical guidance.
Related Articles
Frequently Asked Questions
Sources
Wharton, S., Lingvay, I., Bogdanski, P., Vale, R. D. D., Jacob, S., Karlsson, T., Shaji, C., Rubino, D., & Garvey, W. T. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), 1077–1087. https://doi.org/10.1056/nejmoa2500969
GLP-1 Pill Information | Wegovy® (semaglutide). (n.d.). https://www.wegovy.com/about-wegovy/the-wegovy-pill.html
Lupkin, S. (2026, January 5). Wegovy obesity pill now available at pharmacies. NPR. https://www.npr.org/sections/shots-health-news/2026/01/05/nx-s1-5667020/wegovy-pill-obesity-weight-loss
Wegovy® (semaglutide) tablet 25 mg, injection 2.4 mg Cost, Coverage, & Savings Resources | NovoCare®. (n.d.). https://www.novocare.com/patient/medicines/wegovy.html
Novo Nordisk. (2026). Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America. PRNewswire. https://www.prnewswire.com/news-releases/novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-now-broadly-available-across-america-302652205.html
